nodes	percent_of_prediction	percent_of_DWPC	metapath
Sirolimus—SLC47A1—Metformin—metabolic syndrome X	0.649	1	CbGbCtD
Sirolimus—EIF4E—cardiovascular system—metabolic syndrome X	0.00662	0.108	CbGeAlD
Sirolimus—EIF4E—kidney—metabolic syndrome X	0.00648	0.105	CbGeAlD
Sirolimus—MTOR—blood vessel—metabolic syndrome X	0.00574	0.0934	CbGeAlD
Sirolimus—EIF4E—liver—metabolic syndrome X	0.00409	0.0666	CbGeAlD
Sirolimus—FGF2—adipose tissue—metabolic syndrome X	0.00356	0.0579	CbGeAlD
Sirolimus—Azotaemia—Metformin—metabolic syndrome X	0.00349	0.052	CcSEcCtD
Sirolimus—Acidosis—Metformin—metabolic syndrome X	0.00335	0.0501	CcSEcCtD
Sirolimus—Nail disorder—Metformin—metabolic syndrome X	0.00286	0.0427	CcSEcCtD
Sirolimus—MTOR—cardiovascular system—metabolic syndrome X	0.00256	0.0417	CbGeAlD
Sirolimus—MTOR—kidney—metabolic syndrome X	0.00251	0.0408	CbGeAlD
Sirolimus—FKBP1A—cardiovascular system—metabolic syndrome X	0.0023	0.0375	CbGeAlD
Sirolimus—MTOR—adipose tissue—metabolic syndrome X	0.00226	0.0368	CbGeAlD
Sirolimus—FKBP1A—kidney—metabolic syndrome X	0.00225	0.0367	CbGeAlD
Sirolimus—Accidental injury—Metformin—metabolic syndrome X	0.0021	0.0313	CcSEcCtD
Sirolimus—FKBP1A—adipose tissue—metabolic syndrome X	0.00203	0.0331	CbGeAlD
Sirolimus—SLC47A1—kidney—metabolic syndrome X	0.00194	0.0315	CbGeAlD
Sirolimus—SLCO1B1—kidney—metabolic syndrome X	0.00191	0.0311	CbGeAlD
Sirolimus—CYP3A7—liver—metabolic syndrome X	0.00176	0.0287	CbGeAlD
Sirolimus—SLC47A1—adipose tissue—metabolic syndrome X	0.00175	0.0284	CbGeAlD
Sirolimus—Neuropathy—Metformin—metabolic syndrome X	0.00174	0.026	CcSEcCtD
Sirolimus—MTOR—liver—metabolic syndrome X	0.00158	0.0258	CbGeAlD
Sirolimus—Ear pain—Metformin—metabolic syndrome X	0.00158	0.0236	CcSEcCtD
Sirolimus—CYP3A7-CYP3A51P—liver—metabolic syndrome X	0.0015	0.0244	CbGeAlD
Sirolimus—Injury—Metformin—metabolic syndrome X	0.00147	0.0219	CcSEcCtD
Sirolimus—FKBP1A—liver—metabolic syndrome X	0.00142	0.0232	CbGeAlD
Sirolimus—Renal impairment—Metformin—metabolic syndrome X	0.00142	0.0211	CcSEcCtD
Sirolimus—Hypoglycaemia—Metformin—metabolic syndrome X	0.00138	0.0206	CcSEcCtD
Sirolimus—Dehydration—Metformin—metabolic syndrome X	0.00125	0.0187	CcSEcCtD
Sirolimus—Liver function test abnormal—Metformin—metabolic syndrome X	0.00124	0.0186	CcSEcCtD
Sirolimus—SLC47A1—liver—metabolic syndrome X	0.00122	0.0199	CbGeAlD
Sirolimus—Breast disorder—Metformin—metabolic syndrome X	0.00122	0.0182	CcSEcCtD
Sirolimus—SLCO1B1—liver—metabolic syndrome X	0.00121	0.0197	CbGeAlD
Sirolimus—ABCB1—blood vessel—metabolic syndrome X	0.00119	0.0194	CbGeAlD
Sirolimus—Abdominal distension—Metformin—metabolic syndrome X	0.00117	0.0175	CcSEcCtD
Sirolimus—Influenza—Metformin—metabolic syndrome X	0.00117	0.0174	CcSEcCtD
Sirolimus—Pancreatitis—Metformin—metabolic syndrome X	0.00114	0.017	CcSEcCtD
Sirolimus—Neutropenia—Metformin—metabolic syndrome X	0.00109	0.0163	CcSEcCtD
Sirolimus—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.00108	0.0162	CcSEcCtD
Sirolimus—Infestation NOS—Metformin—metabolic syndrome X	0.00104	0.0155	CcSEcCtD
Sirolimus—Infestation—Metformin—metabolic syndrome X	0.00104	0.0155	CcSEcCtD
Sirolimus—Neuropathy peripheral—Metformin—metabolic syndrome X	0.00102	0.0152	CcSEcCtD
Sirolimus—Hepatobiliary disease—Metformin—metabolic syndrome X	0.000983	0.0147	CcSEcCtD
Sirolimus—CYP3A5—kidney—metabolic syndrome X	0.000981	0.016	CbGeAlD
Sirolimus—Rhinitis—Metformin—metabolic syndrome X	0.000935	0.014	CcSEcCtD
Sirolimus—Hypoaesthesia—Metformin—metabolic syndrome X	0.000928	0.0138	CcSEcCtD
Sirolimus—Oedema peripheral—Metformin—metabolic syndrome X	0.000919	0.0137	CcSEcCtD
Sirolimus—Connective tissue disorder—Metformin—metabolic syndrome X	0.000916	0.0137	CcSEcCtD
Sirolimus—CYP3A5—adipose tissue—metabolic syndrome X	0.000884	0.0144	CbGeAlD
Sirolimus—Cardiac disorder—Metformin—metabolic syndrome X	0.000866	0.0129	CcSEcCtD
Sirolimus—Angiopathy—Metformin—metabolic syndrome X	0.000846	0.0126	CcSEcCtD
Sirolimus—Immune system disorder—Metformin—metabolic syndrome X	0.000842	0.0126	CcSEcCtD
Sirolimus—Mediastinal disorder—Metformin—metabolic syndrome X	0.000841	0.0125	CcSEcCtD
Sirolimus—Chills—Metformin—metabolic syndrome X	0.000837	0.0125	CcSEcCtD
Sirolimus—Malnutrition—Metformin—metabolic syndrome X	0.000812	0.0121	CcSEcCtD
Sirolimus—Flatulence—Metformin—metabolic syndrome X	0.0008	0.0119	CcSEcCtD
Sirolimus—Muscle spasms—Metformin—metabolic syndrome X	0.000781	0.0116	CcSEcCtD
Sirolimus—Tremor—Metformin—metabolic syndrome X	0.000761	0.0114	CcSEcCtD
Sirolimus—Ill-defined disorder—Metformin—metabolic syndrome X	0.000753	0.0112	CcSEcCtD
Sirolimus—CYP3A4—kidney—metabolic syndrome X	0.000736	0.012	CbGeAlD
Sirolimus—Malaise—Metformin—metabolic syndrome X	0.000732	0.0109	CcSEcCtD
Sirolimus—Syncope—Metformin—metabolic syndrome X	0.000728	0.0109	CcSEcCtD
Sirolimus—Palpitations—Metformin—metabolic syndrome X	0.000717	0.0107	CcSEcCtD
Sirolimus—Loss of consciousness—Metformin—metabolic syndrome X	0.000714	0.0106	CcSEcCtD
Sirolimus—Hypertension—Metformin—metabolic syndrome X	0.000701	0.0105	CcSEcCtD
Sirolimus—Chest pain—Metformin—metabolic syndrome X	0.000691	0.0103	CcSEcCtD
Sirolimus—Myalgia—Metformin—metabolic syndrome X	0.000691	0.0103	CcSEcCtD
Sirolimus—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.000686	0.0102	CcSEcCtD
Sirolimus—Discomfort—Metformin—metabolic syndrome X	0.000683	0.0102	CcSEcCtD
Sirolimus—Oedema—Metformin—metabolic syndrome X	0.000663	0.00989	CcSEcCtD
Sirolimus—Infection—Metformin—metabolic syndrome X	0.000658	0.00982	CcSEcCtD
Sirolimus—Shock—Metformin—metabolic syndrome X	0.000652	0.00973	CcSEcCtD
Sirolimus—Nervous system disorder—Metformin—metabolic syndrome X	0.00065	0.0097	CcSEcCtD
Sirolimus—Thrombocytopenia—Metformin—metabolic syndrome X	0.000649	0.00968	CcSEcCtD
Sirolimus—Skin disorder—Metformin—metabolic syndrome X	0.000644	0.0096	CcSEcCtD
Sirolimus—Hyperhidrosis—Metformin—metabolic syndrome X	0.000641	0.00956	CcSEcCtD
Sirolimus—Anorexia—Metformin—metabolic syndrome X	0.000632	0.00942	CcSEcCtD
Sirolimus—CYP3A5—liver—metabolic syndrome X	0.00062	0.0101	CbGeAlD
Sirolimus—Hypotension—Metformin—metabolic syndrome X	0.000619	0.00924	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000604	0.00901	CcSEcCtD
Sirolimus—Paraesthesia—Metformin—metabolic syndrome X	0.000595	0.00888	CcSEcCtD
Sirolimus—Dyspnoea—Metformin—metabolic syndrome X	0.000591	0.00881	CcSEcCtD
Sirolimus—Somnolence—Metformin—metabolic syndrome X	0.000589	0.00879	CcSEcCtD
Sirolimus—Dyspepsia—Metformin—metabolic syndrome X	0.000583	0.0087	CcSEcCtD
Sirolimus—Decreased appetite—Metformin—metabolic syndrome X	0.000576	0.00859	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000572	0.00854	CcSEcCtD
Sirolimus—Constipation—Metformin—metabolic syndrome X	0.000567	0.00845	CcSEcCtD
Sirolimus—Feeling abnormal—Metformin—metabolic syndrome X	0.000546	0.00815	CcSEcCtD
Sirolimus—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000542	0.00808	CcSEcCtD
Sirolimus—ABCB1—cardiovascular system—metabolic syndrome X	0.000533	0.00867	CbGeAlD
Sirolimus—Abdominal pain—Metformin—metabolic syndrome X	0.000524	0.00782	CcSEcCtD
Sirolimus—ABCB1—kidney—metabolic syndrome X	0.000521	0.00849	CbGeAlD
Sirolimus—Asthenia—Metformin—metabolic syndrome X	0.000475	0.00709	CcSEcCtD
Sirolimus—ABCB1—adipose tissue—metabolic syndrome X	0.00047	0.00765	CbGeAlD
Sirolimus—Pruritus—Metformin—metabolic syndrome X	0.000469	0.007	CcSEcCtD
Sirolimus—CYP3A4—liver—metabolic syndrome X	0.000465	0.00758	CbGeAlD
Sirolimus—Diarrhoea—Metformin—metabolic syndrome X	0.000453	0.00676	CcSEcCtD
Sirolimus—Dizziness—Metformin—metabolic syndrome X	0.000438	0.00654	CcSEcCtD
Sirolimus—Vomiting—Metformin—metabolic syndrome X	0.000421	0.00629	CcSEcCtD
Sirolimus—Rash—Metformin—metabolic syndrome X	0.000418	0.00623	CcSEcCtD
Sirolimus—Dermatitis—Metformin—metabolic syndrome X	0.000417	0.00623	CcSEcCtD
Sirolimus—Headache—Metformin—metabolic syndrome X	0.000415	0.00619	CcSEcCtD
Sirolimus—Nausea—Metformin—metabolic syndrome X	0.000394	0.00587	CcSEcCtD
Sirolimus—ABCB1—liver—metabolic syndrome X	0.000329	0.00536	CbGeAlD
Sirolimus—FGF2—Signaling Pathways—IGF2—metabolic syndrome X	3.34e-05	0.00015	CbGpPWpGaD
Sirolimus—SLCO1B1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	3.31e-05	0.000149	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—HDAC3—metabolic syndrome X	3.3e-05	0.000149	CbGpPWpGaD
Sirolimus—FGF2—Disease—IRS1—metabolic syndrome X	3.3e-05	0.000149	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—SCARB1—metabolic syndrome X	3.28e-05	0.000148	CbGpPWpGaD
Sirolimus—MTOR—Disease—LPL—metabolic syndrome X	3.28e-05	0.000147	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CYBA—metabolic syndrome X	3.27e-05	0.000147	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—APOB—metabolic syndrome X	3.24e-05	0.000146	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—LPA—metabolic syndrome X	3.23e-05	0.000145	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—GCKR—metabolic syndrome X	3.23e-05	0.000145	CbGpPWpGaD
Sirolimus—ABCB1—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	3.22e-05	0.000145	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—GHRL—metabolic syndrome X	3.2e-05	0.000144	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—SREBF1—metabolic syndrome X	3.18e-05	0.000143	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CCL5—metabolic syndrome X	3.16e-05	0.000142	CbGpPWpGaD
Sirolimus—FGF2—Disease—INS—metabolic syndrome X	3.16e-05	0.000142	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—PLA2G4A—metabolic syndrome X	3.15e-05	0.000142	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—PLA2G6—metabolic syndrome X	3.13e-05	0.000141	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—HMGCR—metabolic syndrome X	3.1e-05	0.000139	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—GOT2—metabolic syndrome X	3.1e-05	0.000139	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—APOA5—metabolic syndrome X	3.1e-05	0.000139	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—LPL—metabolic syndrome X	3.09e-05	0.000139	CbGpPWpGaD
Sirolimus—MTOR—Signaling by NGF—AKT1—metabolic syndrome X	3.08e-05	0.000139	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—IRS1—metabolic syndrome X	3.05e-05	0.000137	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	3.04e-05	0.000137	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CRP—metabolic syndrome X	3.04e-05	0.000137	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CNR1—metabolic syndrome X	3.03e-05	0.000136	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—FABP4—metabolic syndrome X	3.02e-05	0.000136	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—ABCA1—metabolic syndrome X	3.01e-05	0.000135	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—SLC2A4—metabolic syndrome X	3.01e-05	0.000135	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—INS—metabolic syndrome X	2.92e-05	0.000131	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—GGT1—metabolic syndrome X	2.91e-05	0.000131	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—GOT1—metabolic syndrome X	2.91e-05	0.000131	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—IL6—metabolic syndrome X	2.91e-05	0.000131	CbGpPWpGaD
Sirolimus—FGF2—Disease—SERPINE1—metabolic syndrome X	2.9e-05	0.000131	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—TRIB3—metabolic syndrome X	2.88e-05	0.00013	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—CCL2—metabolic syndrome X	2.88e-05	0.000129	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—HSD11B1—metabolic syndrome X	2.87e-05	0.000129	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—IGF1—metabolic syndrome X	2.83e-05	0.000127	CbGpPWpGaD
Sirolimus—FGF2—Disease—NOS3—metabolic syndrome X	2.77e-05	0.000125	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—ABCA1—metabolic syndrome X	2.76e-05	0.000124	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—SLC2A4—metabolic syndrome X	2.76e-05	0.000124	CbGpPWpGaD
Sirolimus—MTOR—Disease—APOE—metabolic syndrome X	2.75e-05	0.000124	CbGpPWpGaD
Sirolimus—MTOR—Disease—APOA1—metabolic syndrome X	2.72e-05	0.000122	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—IL6—metabolic syndrome X	2.69e-05	0.000121	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—AKT1—metabolic syndrome X	2.68e-05	0.000121	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—SERPINE1—metabolic syndrome X	2.68e-05	0.000121	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—GGT1—metabolic syndrome X	2.67e-05	0.00012	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—GOT1—metabolic syndrome X	2.67e-05	0.00012	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IRS1—metabolic syndrome X	2.65e-05	0.000119	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—AGT—metabolic syndrome X	2.65e-05	0.000119	CbGpPWpGaD
Sirolimus—ABCB1—Transmembrane transport of small molecules—APOB—metabolic syndrome X	2.64e-05	0.000119	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—metabolic syndrome X	2.64e-05	0.000119	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—FMO3—metabolic syndrome X	2.61e-05	0.000118	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—LEP—metabolic syndrome X	2.59e-05	0.000117	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—APOE—metabolic syndrome X	2.59e-05	0.000117	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—NAMPT—metabolic syndrome X	2.58e-05	0.000116	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—IL6—metabolic syndrome X	2.57e-05	0.000116	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—LIPC—metabolic syndrome X	2.57e-05	0.000115	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—GCK—metabolic syndrome X	2.57e-05	0.000115	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—NOS3—metabolic syndrome X	2.56e-05	0.000115	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—APOA1—metabolic syndrome X	2.56e-05	0.000115	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—G6PD—metabolic syndrome X	2.56e-05	0.000115	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—APOC3—metabolic syndrome X	2.55e-05	0.000115	CbGpPWpGaD
Sirolimus—FGF2—Disease—PTGS2—metabolic syndrome X	2.54e-05	0.000114	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—HDAC3—metabolic syndrome X	2.49e-05	0.000112	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—AKT1—metabolic syndrome X	2.48e-05	0.000112	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—IGF2—metabolic syndrome X	2.48e-05	0.000111	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—CETP—metabolic syndrome X	2.48e-05	0.000111	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—APOB—metabolic syndrome X	2.47e-05	0.000111	CbGpPWpGaD
Sirolimus—EIF4E—Gene Expression—AKT1—metabolic syndrome X	2.47e-05	0.000111	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	2.46e-05	0.000111	CbGpPWpGaD
Sirolimus—MTOR—Disease—IRS1—metabolic syndrome X	2.45e-05	0.00011	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—LPA—metabolic syndrome X	2.44e-05	0.00011	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—GCKR—metabolic syndrome X	2.44e-05	0.00011	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—TGFB1—metabolic syndrome X	2.42e-05	0.000109	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—PLA2G4A—metabolic syndrome X	2.4e-05	0.000108	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—APOB—metabolic syndrome X	2.4e-05	0.000108	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—SCARB1—metabolic syndrome X	2.37e-05	0.000107	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—AKT1—metabolic syndrome X	2.37e-05	0.000107	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PLA2G6—metabolic syndrome X	2.36e-05	0.000106	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—LPL—metabolic syndrome X	2.36e-05	0.000106	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CCL5—metabolic syndrome X	2.35e-05	0.000106	CbGpPWpGaD
Sirolimus—MTOR—Disease—INS—metabolic syndrome X	2.35e-05	0.000106	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—PLA2G4A—metabolic syndrome X	2.34e-05	0.000105	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—APOA5—metabolic syndrome X	2.34e-05	0.000105	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—EPHX2—metabolic syndrome X	2.33e-05	0.000105	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—MLXIPL—metabolic syndrome X	2.33e-05	0.000105	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—IRS1—metabolic syndrome X	2.31e-05	0.000104	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—TGFB1—metabolic syndrome X	2.31e-05	0.000104	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—SREBF1—metabolic syndrome X	2.3e-05	0.000104	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—LPL—metabolic syndrome X	2.3e-05	0.000103	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—AKT1—metabolic syndrome X	2.28e-05	0.000102	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—APOB—metabolic syndrome X	2.27e-05	0.000102	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—CD36—metabolic syndrome X	2.24e-05	0.000101	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—HMGCR—metabolic syndrome X	2.24e-05	0.000101	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—GOT2—metabolic syndrome X	2.24e-05	0.000101	CbGpPWpGaD
Sirolimus—ABCB1—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	2.23e-05	0.0001	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—INS—metabolic syndrome X	2.21e-05	9.96e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—PLA2G4A—metabolic syndrome X	2.21e-05	9.93e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—G6PC2—metabolic syndrome X	2.19e-05	9.86e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CCL2—metabolic syndrome X	2.18e-05	9.8e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—TRIB3—metabolic syndrome X	2.17e-05	9.77e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—LPL—metabolic syndrome X	2.17e-05	9.75e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—SERPINE1—metabolic syndrome X	2.16e-05	9.7e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—IGF1—metabolic syndrome X	2.14e-05	9.64e-05	CbGpPWpGaD
Sirolimus—ABCB1—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	2.09e-05	9.41e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—PPARA—metabolic syndrome X	2.09e-05	9.38e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—CD36—metabolic syndrome X	2.06e-05	9.26e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—NOS3—metabolic syndrome X	2.06e-05	9.26e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—SERPINE1—metabolic syndrome X	2.03e-05	9.15e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—AGT—metabolic syndrome X	2.02e-05	9.09e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—ABCA1—metabolic syndrome X	2e-05	8.98e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—SLC2A4—metabolic syndrome X	2e-05	8.98e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—APOE—metabolic syndrome X	1.98e-05	8.9e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—AGT—metabolic syndrome X	1.96e-05	8.83e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—APOA1—metabolic syndrome X	1.96e-05	8.8e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—NAMPT—metabolic syndrome X	1.95e-05	8.77e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—NOS3—metabolic syndrome X	1.94e-05	8.74e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—LIPC—metabolic syndrome X	1.94e-05	8.71e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—GCK—metabolic syndrome X	1.94e-05	8.71e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—GOT1—metabolic syndrome X	1.93e-05	8.7e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—GGT1—metabolic syndrome X	1.93e-05	8.7e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—APOC3—metabolic syndrome X	1.92e-05	8.66e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—APOE—metabolic syndrome X	1.92e-05	8.66e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—LEP—metabolic syndrome X	1.92e-05	8.66e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—PPARA—metabolic syndrome X	1.91e-05	8.61e-05	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—IL6—metabolic syndrome X	1.91e-05	8.58e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—APOA1—metabolic syndrome X	1.9e-05	8.56e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—PTGS2—metabolic syndrome X	1.88e-05	8.47e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—CETP—metabolic syndrome X	1.87e-05	8.41e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—FABP4—metabolic syndrome X	1.86e-05	8.38e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—AGT—metabolic syndrome X	1.85e-05	8.34e-05	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	1.83e-05	8.25e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—TGFB1—metabolic syndrome X	1.83e-05	8.25e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—IL6—metabolic syndrome X	1.82e-05	8.2e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—APOE—metabolic syndrome X	1.82e-05	8.17e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—APOA1—metabolic syndrome X	1.8e-05	8.08e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—SCARB1—metabolic syndrome X	1.79e-05	8.05e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—HSD11B1—metabolic syndrome X	1.77e-05	7.95e-05	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—AKT1—metabolic syndrome X	1.76e-05	7.92e-05	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—IL6—metabolic syndrome X	1.74e-05	7.83e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—SREBF1—metabolic syndrome X	1.74e-05	7.81e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—PPARG—metabolic syndrome X	1.72e-05	7.75e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—IRS1—metabolic syndrome X	1.72e-05	7.72e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—TGFB1—metabolic syndrome X	1.69e-05	7.62e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—INS—metabolic syndrome X	1.69e-05	7.6e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—GOT2—metabolic syndrome X	1.69e-05	7.6e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—HMGCR—metabolic syndrome X	1.69e-05	7.6e-05	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—AKT1—metabolic syndrome X	1.69e-05	7.6e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—AKT1—metabolic syndrome X	1.68e-05	7.57e-05	CbGpPWpGaD
Sirolimus—ABCB1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	1.66e-05	7.45e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—INS—metabolic syndrome X	1.64e-05	7.39e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—APOB—metabolic syndrome X	1.64e-05	7.38e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CCL2—metabolic syndrome X	1.62e-05	7.28e-05	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—AKT1—metabolic syndrome X	1.61e-05	7.23e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—PLA2G4A—metabolic syndrome X	1.6e-05	7.18e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—IGF1—metabolic syndrome X	1.59e-05	7.15e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—PPARG—metabolic syndrome X	1.58e-05	7.12e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—G6PD—metabolic syndrome X	1.57e-05	7.08e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—LPL—metabolic syndrome X	1.57e-05	7.05e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—INS—metabolic syndrome X	1.55e-05	6.98e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—ALB—metabolic syndrome X	1.55e-05	6.97e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	1.54e-05	6.91e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—SERPINE1—metabolic syndrome X	1.51e-05	6.79e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—ABCA1—metabolic syndrome X	1.51e-05	6.78e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—SLC2A4—metabolic syndrome X	1.51e-05	6.78e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—GCKR—metabolic syndrome X	1.5e-05	6.76e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—LPA—metabolic syndrome X	1.5e-05	6.76e-05	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IL6—metabolic syndrome X	1.5e-05	6.73e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—CD36—metabolic syndrome X	1.49e-05	6.69e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—NOS3—metabolic syndrome X	1.48e-05	6.67e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—GGT1—metabolic syndrome X	1.46e-05	6.56e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—GOT1—metabolic syndrome X	1.46e-05	6.56e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	1.45e-05	6.54e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—NOS3—metabolic syndrome X	1.44e-05	6.48e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—APOA5—metabolic syndrome X	1.44e-05	6.48e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—ALB—metabolic syndrome X	1.42e-05	6.4e-05	CbGpPWpGaD
Sirolimus—Tacrolimus—ALB—metabolic syndrome X	1.41e-05	1	CrCbGaD
Sirolimus—CYP3A5—Metabolism—PPARA—metabolic syndrome X	1.38e-05	6.22e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—IL6—metabolic syndrome X	1.38e-05	6.22e-05	CbGpPWpGaD
Sirolimus—FGF2—Immune System—AKT1—metabolic syndrome X	1.38e-05	6.21e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—TGFB1—metabolic syndrome X	1.36e-05	6.12e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—NOS3—metabolic syndrome X	1.36e-05	6.12e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—PTGS2—metabolic syndrome X	1.36e-05	6.1e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—AGT—metabolic syndrome X	1.34e-05	6.03e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	1.34e-05	6.02e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—APOE—metabolic syndrome X	1.31e-05	5.91e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—APOA1—metabolic syndrome X	1.3e-05	5.84e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—TGFB1—metabolic syndrome X	1.28e-05	5.78e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—IL6—metabolic syndrome X	1.28e-05	5.75e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—AKT1—metabolic syndrome X	1.27e-05	5.74e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—PTGS2—metabolic syndrome X	1.24e-05	5.6e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—APOB—metabolic syndrome X	1.24e-05	5.57e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	1.2e-05	5.42e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	1.2e-05	5.4e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—LIPC—metabolic syndrome X	1.19e-05	5.37e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—GCK—metabolic syndrome X	1.19e-05	5.37e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—APOC3—metabolic syndrome X	1.19e-05	5.33e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—LPL—metabolic syndrome X	1.18e-05	5.32e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—AKT1—metabolic syndrome X	1.18e-05	5.3e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—CETP—metabolic syndrome X	1.15e-05	5.18e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—PPARG—metabolic syndrome X	1.14e-05	5.14e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—CD36—metabolic syndrome X	1.12e-05	5.05e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—INS—metabolic syndrome X	1.12e-05	5.05e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL6—metabolic syndrome X	1.11e-05	5e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	1.1e-05	4.96e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	1.07e-05	4.81e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PPARA—metabolic syndrome X	1.04e-05	4.7e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	1.04e-05	4.68e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—GOT2—metabolic syndrome X	1.04e-05	4.68e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—ALB—metabolic syndrome X	1.03e-05	4.63e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—IL6—metabolic syndrome X	1.03e-05	4.61e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—AKT1—metabolic syndrome X	1.02e-05	4.61e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—AGT—metabolic syndrome X	1.01e-05	4.55e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—APOE—metabolic syndrome X	9.9e-06	4.46e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—NOS3—metabolic syndrome X	9.83e-06	4.42e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—APOA1—metabolic syndrome X	9.79e-06	4.41e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—IL6—metabolic syndrome X	9.68e-06	4.35e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—TGFB1—metabolic syndrome X	9.53e-06	4.29e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—AKT1—metabolic syndrome X	9.46e-06	4.26e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	9.28e-06	4.17e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	9.28e-06	4.17e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—PTGS2—metabolic syndrome X	8.99e-06	4.05e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—GOT1—metabolic syndrome X	8.99e-06	4.04e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—GGT1—metabolic syndrome X	8.99e-06	4.04e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—AKT1—metabolic syndrome X	8.93e-06	4.02e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PPARG—metabolic syndrome X	8.63e-06	3.88e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—INS—metabolic syndrome X	8.46e-06	3.81e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—ALB—metabolic syndrome X	7.76e-06	3.49e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—APOB—metabolic syndrome X	7.62e-06	3.43e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—NOS3—metabolic syndrome X	7.42e-06	3.34e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	7.42e-06	3.34e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—LPL—metabolic syndrome X	7.28e-06	3.28e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—IL6—metabolic syndrome X	7.18e-06	3.23e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—CD36—metabolic syndrome X	6.92e-06	3.11e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—AKT1—metabolic syndrome X	6.81e-06	3.07e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PTGS2—metabolic syndrome X	6.79e-06	3.05e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—AKT1—metabolic syndrome X	6.63e-06	2.98e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PPARA—metabolic syndrome X	6.43e-06	2.89e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—AKT1—metabolic syndrome X	6.25e-06	2.81e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—AGT—metabolic syndrome X	6.23e-06	2.8e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—APOE—metabolic syndrome X	6.1e-06	2.75e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—APOA1—metabolic syndrome X	6.03e-06	2.71e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PPARG—metabolic syndrome X	5.32e-06	2.39e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—INS—metabolic syndrome X	5.21e-06	2.35e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ALB—metabolic syndrome X	4.78e-06	2.15e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—NOS3—metabolic syndrome X	4.57e-06	2.06e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—AKT1—metabolic syndrome X	4.52e-06	2.03e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	4.18e-06	1.88e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—AKT1—metabolic syndrome X	3.41e-06	1.53e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—AKT1—metabolic syndrome X	2.1e-06	9.46e-06	CbGpPWpGaD
